GGrantIndex
← Search

CORE--CELL ANALYSIS FACILITY

$0P30FY2000CANIH

Roswell Park Cancer Institute, Buffalo NY

Investigators

Linked publications, trials & patents

Trial NCT07082270Trial NCT06202066Trial NCT05589844Trial NCT05338905Trial NCT05292521Trial NCT05231122Trial NCT04607291Trial NCT04533542Trial NCT04530812Trial NCT04526587Trial NCT04379518Trial NCT04358315Trial NCT04348747Trial NCT04298606Trial NCT04290962Trial NCT04269213Trial NCT04231539Trial NCT04207190Trial NCT04119830Trial NCT04110249Trial NCT04109924Trial NCT04093323Trial NCT04081389Trial NCT04073745Trial NCT04068649Trial NCT04067830Trial NCT04060446Trial NCT04032418Trial NCT04000581Trial NCT03965234Trial NCT03935347Trial NCT03899987Trial NCT03897270Trial NCT03895918Trial NCT03881735Trial NCT03880422Trial NCT03879694Trial NCT03865472Trial NCT03851081Trial NCT03793907Trial NCT03789877Trial NCT03751449Trial NCT03751436Trial NCT03736720Trial NCT03735589Trial NCT03735095Trial NCT03727789Trial NCT03727061Trial NCT03709550Trial NCT03691376Trial NCT03688945Trial NCT03685695Trial NCT03683147Trial NCT03680235Trial NCT03679585Trial NCT03679559Trial NCT03678350Trial NCT03630601Trial NCT03574792Trial NCT03457142Trial NCT03403634Trial NCT03384836Trial NCT03358719Trial NCT03348748Trial NCT03333486Trial NCT03297489Trial NCT03211416Trial NCT03206047Trial NCT03192397Trial NCT03090412Trial NCT03017131Trial NCT03011736Trial NCT02965976Trial NCT02955290Trial NCT02953457Trial NCT02947386Trial NCT02877641Trial NCT02857374Trial NCT02853318Trial NCT02833506Trial NCT02713373Trial NCT02650986Trial NCT02575885Trial NCT02575508Trial NCT02531906Trial NCT02474095Trial NCT02455557Trial NCT02452463Trial NCT02414724Trial NCT02399215Trial NCT02393755Trial NCT02334865Trial NCT02287727Trial NCT02227940Trial NCT02170389Trial NCT02166905Trial NCT02159950Trial NCT02119728Trial NCT02100254Trial NCT02072486

Abstract

The Institute Cell Analysis Resource provides morphological services at both the light and electron microscope (EM) levels of resolution to RPCI investigators, and assists in experimental design and interpretation of the results obtained. The Resource is under the day-to-day supervision of Dr. Jennifer Black, and is currently staffed by three technicians, Ms. Ogden, Mr. Hurley and Ms. Vaughan. The capabilities of the Unit include transmission and scanning EM, confocal microscopy, frozen sectioning and cryoultramicrotomy, paraffin embedding, sectioning and staining, as well as specialized techniques such as pre- and post-embedding immnocyto-chemistry, immunohistochemistry on paraffin sections, immunofluorescence microscopy, scanning immuno-EM, quantitative EM autoradiography, and in situ hybridization. It is equipped with all the required instrumentation to perform these functions in an efficient and cost-effective manner. A major value of the Resource lies in the custom methods development services it provides in a variety of highly specialized morphological techniques and approaches, services which cannot be readily obtained from outside sources. The Unit also provides instruction in morphological techniques and use of appropriate instrumentation. During a recent 12-month period, the Resource contributed to the research of 29 senior investigators from 12 clinical and scientific departments (representing all of the CCSG Programs), supported 46 research grants, and provided data which were included in 32 duplication and 22 abstracts. Studies performed during the project period contributed to the generation of 18 new grant applications and 2 industrial contracts, and are included in 5 pending applications. Over 91% of overall Resource usage was by peer reviewed funded investigators. A charge-back system is in place for use of routine services and fees for long-term specialized services are arranged on an individual basis. In the future, the Cell Analysis Resource will continue to provide state-of-the- art morphological information at both the light and EM levels of resolution to RPCI investigators at a art morphological information at both the light and EM levels of resolution to RPCI investigators at a reasonable cost.

View original record on NIH RePORTER →